GSK Leads Way With Real World Data, But Others Follow – The Pink Sheet
Dan Renick comments on the importance of value demonstration for respiratory disease treatments in The Pink Sheet.
What’s the Deal – The Wall Street Journal
Pharma Industry Firm Moves for More Space
Precision for Value, a company that helps bring pharmaceutical products to market, has found a larger home at One Grand Central Place.
ACT Oncology Wins the PACT 2016 Enterprise Award for Emerging Healthcare Companies
Flemington, N.J., May 19, 2016 – ACT Oncology announced today it has been awarded the Philadelphia Alliance for Capital and Technologies (PACT) 2016 Enterprise Award for Emerging Healthcare companies. The Enterprise Awards, held annually, are the region’s most prestigious business honors for innovative life sciences and technology companies, leaders, and entrepreneurs.
Peter Neumann, Leader in Health Economics and Outcomes Research, Joins Precision Health Economics as Advisor
Peter Neumann, Leader in Health Economics and Outcomes Research, Joins Precision Health Economics as Advisor
Los Angeles, May 17, 2016 — Precision Health Economics (PHE), a global leader in health economic research, policy, and analytics, announced today that Peter Neumann, ScD has joined PHE in the role of principal scientific advisor.
Commentary: The Utility of Cancer Value Frameworks for Patients, Payers
Precision’s Chandra and Shafrin Address Value Frameworks in JAMA